Breathe Technologies, Inc.

Founded in 2005, Breathe Technologies has emerged as a key player in the health care industry, pioneering innovative medical technologies to combat lung diseases. The company's flagship product, NIOV, is a breakthrough one-pound wearable ventilator leveraging the company’s proprietary, open ventilation platform. This disruptive technology has garnered FDA clearance and is commercially available in both institutional and homecare settings. Moreover, the Life2000h Ventilator, an extension of NIOV, has also obtained FDA clearance for critical care and life support uses in hospital and home environments. The recent $6.25M Venture Round investment in October 2017 underscores the growing confidence in Breathe Technologies' potential to revolutionize respiratory care. This investment injection not only underscores the market's recognition of the company's technological prowess, but also enhances its capacity to drive further innovation and expand its market reach. As the company continues to push the boundaries of medical technology, it remains an exciting prospect for venture capitalists looking for opportunities in the ever-evolving health care sector. Breathe Technologies' commitment to addressing critical healthcare challenges positions it as a formidable contender in the global medtech landscape. With its headquarter situated in the United States, the company is strategically positioned to impact the health care sector on a global scale. For more information about Breathe Technologies, visit their website at www.breathetechnologies.com to stay updated on their latest breakthroughs and advancements in medical technology.